[Experimental research with a new percutaneously insertable and expandable vascular prosthesis].
Restenosis and occlusion are the most common reasons why transluminal balloon angioplasty may fail to provide long-term benefit. To prevent restenosis and occlusion of diseased arteries after angioplasty an arterial endoprosthesis has been developed which is positioned to the balloon of an angioplasty catheter and which consists of a stainless steel pliable and elastic tube. With the inflation of the balloon the endoprosthesis will dilate and give the arterial wall a new mechanical support. This new device has been implanted in 12 experimental dogs in arteries of different size and lumen. The longest patency rate of nine months was observed with the completely developed method.
Strecker
E P
EP
Abteilung für Strahlendiagnostik und Nuklearmedizin, Diakonissenkrankenhaus Karlsruhe-Rüppurr, Universität Karlsruhe.
Berg
G
G
Weber
H
H
Bohl
M
M
Dietrich
B
B
D000800:Angioplasty, Balloon / Q000295:instrumentation / Q000379:methods; D000818:Animals; D001157:Arterial Occlusive Diseases / Q000517:prevention & control / Q000628:therapy; D001807:Blood Vessel Prosthesis; D004285:Dogs; D005069:Evaluation Studies as Topic; D011474:Prosthesis Design; D012008:Recurrence; D014654:Vascular Patency
Experimentelle Untersuchungen mit einer neuen perkutan einführbaren und aufdehnbaren Gefässendoprothese.